Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy.

Saved in:
Bibliographic Details
Title: Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy.
Authors: Van Ry PM; Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada, USA., Wuebbles RD; Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada, USA., Key M; Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada, USA., Burkin DJ; Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada, USA. Electronic address: dburkin@medicine.nevada.edu.
Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2015 Aug; Vol. 23 (8), pp. 1285-1297. Date of Electronic Publication: 2015 Jun 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1525-0024
DOI:10.1038/mt.2015.105